Penserra Capital Management LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 188 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$253
+2.4%
10,548
+36.0%
0.01%0.0%
Q2 2023$247
+27.3%
7,755
+22.1%
0.01%
+25.0%
Q1 2023$194
-20.8%
6,350
+1.3%
0.00%
-20.0%
Q4 2022$245
-99.9%
6,270
-35.0%
0.01%
-61.5%
Q3 2022$459,000
+329.0%
9,639
+247.2%
0.01%
+333.3%
Q2 2022$107,000
+10.3%
2,776
+63.3%
0.00%
+50.0%
Q1 2022$97,000
-26.5%
1,700
+11.5%
0.00%
-33.3%
Q3 2021$132,000
-27.9%
1,525
+7.0%
0.00%0.0%
Q2 2021$183,000
+76.0%
1,425
+8.8%
0.00%
+50.0%
Q1 2021$104,000
-3.7%
1,310
-1.9%
0.00%
-33.3%
Q4 2020$108,0001,3350.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$56,443,76354.70%
HSG Holding Ltd 796,089$19,145,9402.05%
Redmile Group, LLC 1,469,725$35,346,8861.68%
ARK Investment Management 8,783,891$211,252,5901.62%
Casdin Capital, LLC 570,000$13,708,5001.52%
Deep Track Capital, LP 1,015,641$24,426,1660.94%
Yiheng Capital Management, L.P. 560,500$13,480,0250.69%
Temasek Holdings (Private) Ltd 4,317,789$103,842,8250.62%
FARALLON CAPITAL MANAGEMENT LLC 4,481,839$107,788,2280.50%
Alphabet Inc. 321,604$7,734,5760.50%
View complete list of BEAM THERAPEUTICS INC shareholders